PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Author: Business Wire
EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners will bring a strong lineup of clinical research and innovation to the upcoming annual ASCRS meeting.
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
LONDON & SEATTLE–(BUSINESS WIRE)– #ophthalmology–Tenpoint Therapeutics, Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that Hen…
Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results f…
xMEMS Labs Powers World’s First AI Sports Glasses with Cowell MEMS Tweeter, Securing Foothold in Booming AI Glasses Market
SANTA CLARA, Calif.–(BUSINESS WIRE)—- $xMEMS #MEMS–xMEMS Labs, Inc., the global leader in solid-state MEMS speaker technology, today announced that its Cowell MEMS tweeter is now shipping in a groundbreaking AI sports glasses product from BleeqUp, …
Neurotech Appoints Beth Marsh as Chief Commercial Officer
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April …
Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling …
Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before mar…
Aldeyra Therapeutics Appoints Chip Clark to Board of Directors
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the app…
20/20 Onsite Recognized by TITAN Health Awards for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments
BOSTON–(BUSINESS WIRE)–20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services – Healthcare.
ModMed Empowers Future Ophthalmic Technicians with Donated EHR Access at Illinois Community Colleges
BOCA RATON, Fla.–(BUSINESS WIRE)–ModMed® is investing in the future of eye care by providing access to its ophthalmology-focused EHR system to three Illinois community colleges.
Glaukos Announces the Release of its 2024 Sustainability Report
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Eyestem’s Eyecyte-RPE™ Trial Shows Vision Rescue for Geographic Atrophy Patients
BENGALURU, India–(BUSINESS WIRE)– #ARVO2025–Eyestem’s Eyecyte-RPE™ trial shows vision rescue for geographic atrophy patients.
Bruno Vision Care Receives FDA Approval for Deseyne® Contact Lens with FusionTechnology™
BOCA RATON, Fla.–(BUSINESS WIRE)–Bruno Vision Care LLC, a leader in eye care innovation, has received approval from the U.S. Food and Drug Administration (FDA) to sell its Deseyne® (vifilcon C) daily disposable contact lens with FusionTechnology™ in …
Marshall B. Ketchum University’s Dr. Mark E. Nakano Recognized as COA Keyperson of the Year for Advocacy, Leadership and Expanding Vision Care Access
FULLERTON, Calif.–(BUSINESS WIRE)–Marshall B. Ketchum University (MBKU) today announced that Dr. Mark E. Nakano, OD, associate dean of clinics and assistant professor at MBKU’s Southern California College of Optometry (SCCO), has been named the 2024 …
OneLegacy Celebrates Donate Life Month Through Outreach and Awareness Activities Promoting the Power of Organ, Eye and Tissue Donation
LOS ANGELES–(BUSINESS WIRE)–OneLegacy, the local organ procurement organization that serves seven counties in Southern California, is joining thousands of organizations, hospitals, transplant centers, and cities across the country to celebrate Nation…
Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced an expansion of its VEVYE® Access for All (“VAFA”) program to include patients currently prescribed Klarity-C D…
NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD
BUSAN, South Korea–(BUSINESS WIRE)– #BiopharmaceuticalCompany–NexThera completed the initial patient enrollment for its Phase 1/2a clinical trial of NT-101, a novel eye drop treatment for wet AMD.